Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2440-2446

  Fu, Yi Ping ^a,c   Yu, Jyh Cherng ^d   Cheng, Ting Chih ^a,c   Lou, M Ann ^e   Hsu, Giu Cheng ^d   Wu, Chia Yun ^a,c   Chen, Sou Tong ^f   Wu, Hurng Sheng ^g   Wu, Pei Ei ^a   Shen, Chen Yang ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^g SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE DNAPKCS; GENE KU70; GENE KU80; GENE LIGASE IV; GENE NHEJ; GENE XRCC4; GENETIC POLYMORPHISM; GENETIC STABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; PRIORITY JOURNAL; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, NUCLEAR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA DAMAGE; DNA HELICASES; DNA LIGASES; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 0037506012     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Vogelstein, B., and Kinzler, K. W. The Genetic Basis of Human Cancer. New York: McGraw-Hill, 2002.
2. Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell, 108: 171-182, 2002.
3. Shen, C. Y., Yu, J. C., Lo, Y. L., Kuo, C. H., Yue, C. T., Jou, Y. S., Huang, C. S., Lung, J. C., and Wu, C. W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res., 60: 3884-3892, 2000.
4. Khanna, K. K., and Jackson, S. P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet., 27: 247-254, 2001.
5. Karran, P. DNA double strand break repair in mammalian cells. Curr. Opin. Genet. Dev., 10: 144-150, 2000.
6. van Gent, D. C., Hoeijmakers, J. H. J., and Kanaar, R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet., 2: 196-206, 2001.
7. O'Driscoll, M., Cerosaletti, K. M., Girard, P. M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S. E., Seidel, J., Gatti, R. A., Varon, R., Oettinger, M. A., Neitzel, H., Jeggo, P. A., and Concannon, P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell, 8: 1175-1185, 2001.
8. Falck, J., Petrini, J. H., Williams, B, R., Lukas, J., and Bartek, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet., 30: 290-294, 2002.
9. Kirk, B. W., Feinsod, M., Favis, R., Kliman, R. M., and Barany, F. Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res., 30: 3295-3311, 2002.
10. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphism of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
11. Le Marchand, L., Sivaraman, L., Pierce, L., Seifried, A., Lum, A., Wilkens, L. R., and Lau, A. F. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res., 58: 4858-4863, 1998.
12. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol Toxicol., 36: 203-232, 1996.
13. Zhu, B. T., and Conney, A. H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res., 58: 2269-2277, 1998.
14. Yang, P. S., Yang, T. L., Liu, C. L., Wu, C. W., and Shen, C. Y. A case-control study of breast cancer in Taiwan. Br. J. Cancer. 75: 752-756, 1997.
15. Lo, Y. L., Yu, J. C., Huang, C. S., Tseng, S. L., Chang, T. M., Chang, K. J., Wu, C. W., and Shen, C. Y. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer, 79: 580-587, 1998.
16. Huang, C, S., Chern, H. D., Chang, K. J., Cheng, C. W., Hsu, S, M., and Shen, C. Y. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res., 59: 4870-4875, 1999.
17. Cheng, C. W., Wu, P. E., Yu, J. C., Huang, C. S., Yue, C. T., Wu, C. W., and Shen, C. Y. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 20: 3814-3823, 2001.
18. Lung, J. C., Chu, J. S., Yu, J. C., Yue, C. T., Lo, Y. L., Shen, C. Y., and Wu, C. W. Aberrant expression of cell cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes Cancer. 34: 276-284, 2002.
19. Kleinbaum, D. G., Kupper L. L., and Morgenstern H. Epidemiologic Research. New York: Van Nostrand Reinhold, 1982.
20. Smith, G. C., and Jackson, S. P. The DNA-dependent protein kinase. Genes Dev., 13: 916-934, 1999.
21. Hoeijmakers, J. H. J. Genome maintenance mechanisms for preventing cancer. Nature (Lond.), 411: 366-374, 2001.
22. Khoury, M. Genetic epidemiology. In: K. J. Rothman and S. Greenland (eds.), Modern Epidemiology, 2nd ed., pp. 609-621. Philadelphia: Lippincott-Raven Publishers, 1998.
23. Kleinbaum, D. G., Kupper, L. L., and Muller, K. E. Applied Regression Analysis and Other Multivariable Methods. Boston: PWS-KENT Publishing Company, 1998.
24. Botto, L. D., and Khoury, M. J. Facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am. J. Epidemiol., 153: 1016-1020, 2001.
25. Weller, G. R., Kysela, B., Roy, R., Tonkin, L. M., Scanlan, E., Della, M., Devine, S. K., Day, J. P., Wilkinson, A., di Fagagna, F., Devine, K. M., Bowater, R. P., Jeggo, P. A., Jackson, S. P., and Doherty, A. J. Identification of a DNA nonhomologous end-joining complex in bacteria. Science (Wash. DC), 297: 1686-1689, 2002.
26. Russo, J., Tay, L. K., and Russo, I. H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat., 2: 5-73, 1982.
27. Kelsey, J. L., Gammon, M. D., and John, E. M. Reproductive factors and breast cancer. Epidemiol. Rev., 15: 36-47, 1993.
28. Narod, S. A. Modifiers of risk of hereditary breast and ovarian cancer. Nat. Rev. Cancer. 2: 113-123, 2002.
29. Kuschel, B., Auranen, A., McBride, S., Novik, K. L., Antoniou, A., Lipscombe, J. M., Day, N. E., Easton, D. F., Ponder, B. A., Pharoah, P. D., and Dunning, A. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet., 11: 1399-1407, 2002.
30. Bernstein, L., Yuan, J. M., Ross, R. K., Pike, M. C., Hanisch, R., Lobo, R., Stanczyk, F., Gao, Y. T., and Henderson, B. E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control, 1: 51-58, 1990.
31. Concannon, P. ATM heterozygosity and cancer risk. Nat. Genet., 32: 89-90, 2002.
32. Elledge, S. J., and Amon, A. The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell. 1: 129-132, 2002.
33. Fitze, G., Cramer, J., Ziegler, A., Schierz, M., Schreiber, M., Kuhlisch, E., Roesner, D., and Schackert, H. K. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet, 359: 1200-1205, 2002.
34. Kim, M. J., Cardiff, R. D., Desai, N., Banach-Petrosky, W. A., Parsons, R., Shen, M. M., and Abate-Shen, C. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc. Natl. Acad. Sci. USA. 99: 2884-2889, 2002.
35. Jones, I. M., Thomas, C. B., Xi, T., Nelson, D. O., and Mohrenweiser, H. W. Base excision repair phenotypes depend on base excision repair genotype in cell lines of healthy people. Proc. Am. Assoc. Cancer Res., 43: 493, 2002.
36. Pharoah, P. D., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., and Ponder, B. A. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet., 3: 33-36, 2002.
37. Thompson, P. A., Shields, P. G., Freudenheim, J, L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F. F., and Ambrosone, C. B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status and breast cancer risk. Cancer Res., 58: 2107-2110, 1998.
38. Dunning, A. M., Healey, C. S., Pharoah, P. D. P., Teare, M. D., Ponder, B. A. J., and Easton, D. F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 8: 843-854, 1999.
39. Guillemette, C., Millikan, R. C., Newman, B., and Housman, D. E. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res., 60: 950-956, 2000.
40. Willett, W. C. Diet and breast cancer. J. Intern. Med., 249: 395-411, 2001.
41. Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., and Shields, P. G. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res., 59: 602-606, 1999.
42. Van Dyck, E., Stasiak, A. Z., Stasiak, A., and West, S. C. Binding of double-strand breaks in DNA by human Rad52 protein. Nature (Lond.), 398: 728-731, 1999.
43. Loeb, L. A. A mutator phenotype in cancer. Cancer Res., 61: 3230-3239, 2001.